Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme.

@article{Hawkins2007PrevalenceAP,
  title={Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme.},
  author={Nathaniel Mark Hawkins and Dongliang Wang and John J V McMurray and Marc Pfeffer and Karl Swedberg and Christopher B. Granger and Salim Yusuf and StuartJ. Pocock and Jan B Ostergren and Eric L. Michelson and FrancisG. Dunn},
  journal={Heart},
  year={2007},
  volume={93 1},
  pages={
          59-64
        }
}
BACKGROUND Electrocardiographic left ventricular hypertrophy (ECG LVH) is a powerful independent predictor of cardiovascular morbidity and mortality in hypertension. OBJECTIVE To determine the contemporary prevalence and prognostic implications of ECG LVH in a broad spectrum of patients with heart failure with and without reduced left ventricular ejection fraction (LVEF). METHODS AND OUTCOME: The Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 17 CITATIONS

Similar Papers

Loading similar papers…